Integrated genetic and pharmacologic interrogation of rare cancers
Identifying therapeutic targets in rare cancers remains challenging due to the paucity of established models to perform preclinical studies. As a proof-of-concept, we developed a patient-derived cancer cell line, CLF-PED-015-T, from a paediatric patient with a rare undifferentiated sarcoma. Here, we...
| Main Authors: | , , , |
|---|---|
| Other Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group,
2016-12-07T16:04:02Z.
|
| Subjects: | |
| Online Access: | Get fulltext |